Advertisement
Advertisement

BDSX

BDSX logo

Biodesix, Inc. Common Stock

7.88
USD
Sponsored
-0.46
-5.46%
Jan 16, 15:59 UTC -5
Closed
exchange

After-Market

8.19

+0.31
+3.94%

BDSX Earnings Reports

Positive Surprise Ratio

BDSX beat 13 of 21 last estimates.

62%

Next Report

Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$24.18M
/
-$1.07
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
+34.64%
/
-33.13%

Biodesix, Inc. Common Stock earnings per share and revenue

On Jan 12, 2026, BDSX reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.87 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 26.24 million, with a --% difference. The market reacted with a +47.99% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -1.07 USD, with revenue projected to reach 24.18 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q4 2025, Biodesix, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 47.99%, changed from $5.46 before the earnings release to $8.08 the day after.
The next earning report is scheduled for May 11, 2026.
Based on 5 analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$1.07 and revenue of $24.18M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement